126 related articles for article (PubMed ID: 8737597)
1. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Blanchard PJ; Perry EK
Clin Chim Acta; 1996 May; 249(1-2):129-39. PubMed ID: 8737597
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
3. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
4. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.
Ogawa K; Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Fujino Y; Nakajima M; Yamamoto T; Akatsu H; Mitsui S; Yamaguchi N
Psychiatry Clin Neurosci; 2000 Aug; 54(4):419-26. PubMed ID: 10997858
[TBL] [Abstract][Full Text] [Related]
5. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
Schneider G; Oepen H; von Wedel HR
Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
[TBL] [Abstract][Full Text] [Related]
6. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
7. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
8. Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review.
Scholefield M; Unwin RD; Cooper GJS
Ageing Res Rev; 2020 Nov; 63():101152. PubMed ID: 32846222
[TBL] [Abstract][Full Text] [Related]
9. AMPK in Neurodegenerative Diseases.
Domise M; Vingtdeux V
Exp Suppl; 2016; 107():153-177. PubMed ID: 27812980
[TBL] [Abstract][Full Text] [Related]
10. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
[TBL] [Abstract][Full Text] [Related]
11. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
[TBL] [Abstract][Full Text] [Related]
12. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
13. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
15. Decreased proline endopeptidase activity in the basal ganglia in Huntington's disease.
Pittaway KM; Reynolds GP; Emson PC
J Neurochem; 1984 Sep; 43(3):878-80. PubMed ID: 6235325
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
[TBL] [Abstract][Full Text] [Related]
18. Lewy bodies and progressive dementia: a critical review and meta-analysis.
Cercy SP; Bylsma FW
J Int Neuropsychol Soc; 1997 Mar; 3(2):179-94. PubMed ID: 9126859
[TBL] [Abstract][Full Text] [Related]
19. Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease.
Cross AJ; Crow TJ; Dawson JM; Ferrier IN; Johnson JA; Peters TJ; Reynolds GP
J Neurochem; 1986 Sep; 47(3):882-9. PubMed ID: 2942642
[TBL] [Abstract][Full Text] [Related]
20. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.
Fritz NE; Kegelmeyer DA; Kloos AD; Linder S; Park A; Kataki M; Adeli A; Agrawal P; Scharre DW; Kostyk SK
Gait Posture; 2016 Oct; 50():1-7. PubMed ID: 27544062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
